REQUEST A DEMO
Total
USD $0.00
Search more companies

Nectar Lifesciences Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nectar Lifesciences Ltd. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

neclife is a pharmaceutical company that operates in the manufacturing of Cephalosporin group Drug Products and utilizes Biomass Cogeneration Project technology.

Headquarters
A-920, 9th Floor,, Naurang House, 21 K G Marg
Delhi; Delhi; Postal Code: 110001

Contact Details: Purchase the Nectar Lifesciences Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Nectar Lifesciences Ltd. report to view the information.
Outstanding Shares:
Purchase the Nectar Lifesciences Ltd. report to view the information.
Registered Capital:
Purchase the Nectar Lifesciences Ltd. report to view the information.
Financial Auditors:
Purchase the Nectar Lifesciences Ltd. report to view the information.
Incorporation Date:
1995
Key Executives
Purchase this report to view the information.
Chairman & Managing Director
Purchase this report to view the information.
Chief Executive
Purchase this report to view the information.
Vice President (Accounts)
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
44.35%
Purchase this report to view the information.
24.21%
Purchase this report to view the information.
20.51%
Purchase this report to view the information.
8.34%
Purchase this report to view the information.
2.57%
Subsidiaries
Chempharma Pvt.Ltd.
100%
Nectar Capital Ltd.
100%
Nectar Lifesciences UK Ltd.
100%
Company Performance
Financial values in the chart are available after Nectar Lifesciences Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
10.53%
Total operating revenue
8.41%
Operating profit (EBIT)
184.38%
EBITDA
72.72%
Net Profit (Loss) for the Period
N/A
Total assets
0.08%
Total equity
0.44%
Operating Profit Margin (ROS)
3.83%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-10.98%
Quick Ratio
-0.04%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?